Amgen Inc. reported a robust quarterly performance, surpassing analyst expectations with a notable revenue increase of 9.4%. ...

Amgen Inc. (NASDAQ:AMGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Amgen Inc. (NASDAQ:AMGN) reported ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

Amgen Inc. enjoyed a significant boost this quarter, thanks to Westwood Holdings Group Inc. enhancing its stake by 30.3%. The ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.

For developers, OpenAI claims GPT-5 is its most powerful coding model to date, outperforming GPT-o3 in benchmarks and ...

This segment is sponsored by Amgen This week we celebrated NBC4’s 8th annual “Stuffing Day” which is the culmination of this ...

Strand Therapeutics announced on Thursday that it landed a $153 million Series B funding led by Kinnevik. The company’s ...

The competitive landscape of the ARMD market in 2025 is dominated by a few key players and a leading product. Eylea, a therapy for age-related molecular degeneration, is projected to command a ...

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that ...

During a Q2 earnings call, the firm discussed progress on an FGFR2b antibody, a subcutaneous version of Blincyto, and ...